|
US20030119029A1
(en)
*
|
1999-04-30 |
2003-06-26 |
Regents Of The University Of Michigan |
Compositions and methods relating to novel benzodiazepine compounds and targets thereof
|
|
US20060025388A1
(en)
*
|
1999-04-30 |
2006-02-02 |
Glick Gary D |
Compositions and methods relating to novel compounds and targets thereof
|
|
US20050113460A1
(en)
*
|
1999-04-30 |
2005-05-26 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
|
US20040176358A1
(en)
*
|
1999-04-30 |
2004-09-09 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
|
US7572788B2
(en)
*
|
1999-04-30 |
2009-08-11 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
|
AU782447C
(en)
*
|
1999-04-30 |
2006-07-13 |
Regents Of The University Of Michigan, The |
Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
|
|
US20050272723A1
(en)
*
|
2004-04-27 |
2005-12-08 |
The Regents Of The University Of Michigan |
Methods and compositions for treating diseases and conditions associated with mitochondrial function
|
|
US20060052369A1
(en)
*
|
2004-09-07 |
2006-03-09 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
|
AU2006203946B2
(en)
*
|
2005-01-03 |
2009-07-23 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
|
WO2007053193A2
(en)
|
2005-06-01 |
2007-05-10 |
The Regents Of The University Of Michigan |
Unsolvated benzodiazepine compositions and methods
|
|
US20070105844A1
(en)
*
|
2005-10-26 |
2007-05-10 |
Regents Of The University Of Michigan |
Therapeutic compositions and methods
|
|
EP2604269B1
(en)
|
2005-11-01 |
2014-09-24 |
The Regents Of The University Of Michigan |
1,4-benzodiazepine-2,5-diones with therapeutic properties
|
|
US7759338B2
(en)
*
|
2006-04-27 |
2010-07-20 |
The Regents Of The University Of Michigan |
Soluble 1,4 benzodiazepine compounds and stable salts thereof
|
|
WO2007146167A1
(en)
|
2006-06-09 |
2007-12-21 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
|
JP5383513B2
(ja)
|
2007-03-09 |
2014-01-08 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
化合物およびその標的に関連する組成物ならびに方法
|
|
AU2008298870C1
(en)
|
2007-09-14 |
2014-10-09 |
The Regents Of The University Of Michigan |
F1F0-ATPase inhibitors and related methods
|
|
BRPI0820477A2
(pt)
|
2007-11-06 |
2015-06-16 |
Univ Michigan |
Compostos de benzodiazepinona úteis no tratamento de afecções da pele
|
|
WO2010030891A2
(en)
|
2008-09-11 |
2010-03-18 |
The Regents Of The University Of Michigan |
Aryl guanidine f1f0-atpase inhibitors and related methods
|
|
US8604023B2
(en)
|
2009-04-17 |
2013-12-10 |
The Regents Of The University Of Michigan |
1,4-benzodiazepinone compounds and their use in treating cancer
|
|
WO2011035124A1
(en)
|
2009-09-18 |
2011-03-24 |
The Regents Of The University Of Michigan |
Benzodiazepinone compounds and methods of treatment using same
|
|
WO2011062766A2
(en)
|
2009-11-17 |
2011-05-26 |
The Regents Of The University Of Michigan |
1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
|
|
JP5856063B2
(ja)
|
2009-11-17 |
2016-02-09 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
治療特性を有する1,4−ベンゾジアゼピン−2,5−ジオンおよび関連化合物
|